INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 5,480.00
-250.00 (-4.36%)
At close: Jul 13, 2026
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 54.72 billion as of July 14, 2026. Its market cap has decreased by -54.67% in one year.
Market Cap
54.72B
Enterprise Value
55.29B
Revenue
5.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,480.00
Market Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 54.72B, a decrease of -74.95%. That is a compound annual growth rate of -7.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 54.72B | -47.76% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JS Corporation | 338.63B |
| Au Brandz Co.,Ltd | 239.57B |
| BAIKSAN Co,. | 200.29B |
| Hwaseung Enterprise | 191.16B |
| SYTS Corp. | 144.41B |
| Nine & Company | 116.89B |
| HWASEUNG Industries | 116.44B |
| The Nature Holdings | 93.00B |